Activation of gp130 by IL-6 soluble IL-6 receptor induces neuronal differentiation

被引:80
作者
März, P
Herget, T
Lang, E
Otten, U
Rose-John, S
机构
[1] Johannes Gutenberg Univ Mainz, Dept Med, Sect Pathophysiol, D-55101 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Sch Med, Inst Physiol Chem & Pathobiochem, D-55099 Mainz, Germany
[3] Univ Basel, Dept Physiol, CH-4051 Basel, Switzerland
基金
中国国家自然科学基金;
关键词
cytokines; NGF; rat; PC12; cells; differentiation;
D O I
10.1111/j.1460-9568.1997.tb01705.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Interleukin-6 (IL-6) on target cells binds to the specific IL-6 receptor (IL-6R) and subsequently induces homodimerization of the signal-transducing protein gp130. Cells which express gp130 but no IL-6R and which therefore do not respond to IL-6 can be stimulated by the complex of IL-6 and soluble IL-6R (sIL-6R). Here we show that on rat pheochromocytoma cells (PC12), the combination of IL-6 and sIL-6R but not IL-6 alone induces expression of c-fos, GAP-43 and neuron-specific enolase followed by neuron-specific differentiation and formation of a neuronal network. The differentiation was dose-and time-dependent and followed the same kinetics as nerve-growth factor (NGF)-induced differentiation. The responses of PC12 cells to IL-6/sIL-6R and NGF were additive, suggesting independent signaling pathways. We demonstrate that activation of gp130 generates a neuronal differentiation signal that is equivalent to and independent of trk/NGF receptor tyrosine kinase. Interestingly, the failure of IL-6 to induce differentiation of PC12 cells is not due to lack of surface expression of IL-6R as IL-6 alone triggered expression of GAP-43 mRNA and protein. We hypothesize that PC12 cells express more gp130 than IL-6R and that the extent of activated gp130 molecules determines the quality of the response.
引用
收藏
页码:2765 / 2773
页数:9
相关论文
共 58 条
[1]   INTERLEUKIN-1-BETA ENHANCES SURVIVAL AND INTERLEUKIN-6 PROTECTS AGAINST MPP(+) NEUROTOXICITY IN CULTURES OF FETAL-RAT DOPAMINERGIC-NEURONS [J].
AKANEYA, Y ;
TAKAHASHI, M ;
HATANAKA, H .
EXPERIMENTAL NEUROLOGY, 1995, 136 (01) :44-52
[2]   INTERLEUKIN-6 IN BIOLOGY AND MEDICINE [J].
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :1-78
[3]  
Baumann H, 1996, J IMMUNOL, V157, P284
[4]   Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients [J].
BlumDegen, D ;
Muller, T ;
Kuhn, W ;
Gerlach, M ;
Przuntek, H ;
Riederer, P .
NEUROSCIENCE LETTERS, 1995, 202 (1-2) :17-20
[5]   NERVE GROWTH FACTOR - PURIFICATION AS A 30,000-MOLECULAR-WEIGHT PROTEIN [J].
BOCCHINI, V ;
ANGELETTI, PU .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1969, 64 (02) :787-+
[6]  
BOLIN LM, 1995, J NEUROCHEM, V64, P850
[7]  
BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561
[8]   Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipolysaccharide or IL-1 beta: A study on IL-6-deficient mice [J].
Chai, Z ;
Gatti, S ;
Toniatti, C ;
Poli, V ;
Bartfai, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :311-316
[9]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[10]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421